View by Specialty

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Retina/Vitreous News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 04, 2024
2 min watch
Save

VIDEO: Ask patients about impact of thyroid eye disease on quality of life

VIDEO: Ask patients about impact of thyroid eye disease on quality of life

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Lisa M. Nijm, MD, JD, discusses the burden of thyroid eye disease and how it affects quality of life.

SPONSORED CONTENT
September 04, 2024
1 min read
Save

FDA clears investigational new drug application for photoreceptor disease therapy

FDA clears investigational new drug application for photoreceptor disease therapy

The FDA cleared an investigational new drug application for OpCT-001, an investigational cell therapy for the treatment of primary photoreceptor diseases, according to a press release from BlueRock Therapeutics.

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

SPONSORED CONTENT
August 30, 2024
2 min read
Save

Tepezza linked with promising re-treatment rates for thyroid eye disease

Tepezza linked with promising re-treatment rates for thyroid eye disease

Less than 25% of patients with thyroid eye disease who underwent a full course of treatment with Tepezza required re-treatment, according to a study published in Ophthalmology.

SPONSORED CONTENT
August 29, 2024
1 min read
Save

Severe COVID-19 may impact retina

Severe COVID-19 may impact retina

Retinal ganglion cell layer thickness was significantly reduced in patients with severe COVID-19, which indicates an affinity for nerve cells, according to research published in the Open Journal of Ophthalmology.

SPONSORED CONTENT
August 29, 2024
1 min read
Save

Delayed diagnosis of congenital optic disc abnormalities may worsen visual prognosis

Delayed diagnosis of congenital optic disc abnormalities may worsen visual prognosis

Delayed diagnosis of congenital optic disc abnormalities increases the risk for complications and may affect visual prognosis, according to a study published in the Open Journal of Ophthalmology.

SPONSORED CONTENT
August 28, 2024
2 min read
Save

Deep-learning model based on retinal images may help assess cardiovascular disease risk

Deep-learning model based on retinal images may help assess cardiovascular disease risk

The retinal image-based, deep-learning cardiac BioAge model accurately stratified individuals by traditional cardiovascular disease risk biomarkers, with leukocyte telomere length inversely related to BioAge score, researchers reported.

SPONSORED CONTENT
August 28, 2024
1 min read
Save

Participant visits complete in phase 2b trial of CLS-AX for wet AMD

Participant visits complete in phase 2b trial of CLS-AX for wet AMD

Clearside Biomedical announced the completion of the final participant visit in its ODYSSEY phase 2b clinical trial of CLS-AX, an axitinib injectable suspension for neovascular age-related macular degeneration.

SPONSORED CONTENT
August 27, 2024
1 min read
Save

Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema

Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema

AiViva Biopharma announced that it has completed enrollment and dosing of the last patient in a phase 1 clinical trial of AIV007 for wet age-related macular degeneration and diabetic macular edema.

SPONSORED CONTENT
August 25, 2024
1 min watch
Save

VIDEO: Eye6 smart glasses improve vision in patients with AMD

VIDEO: Eye6 smart glasses improve vision in patients with AMD

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Kelley Sheets of Eyedaptic gives an overview of the Eye6 wearable vision aid for patients with age-related macular degeneration.

SPONSORED CONTENT
August 21, 2024
1 min read
Save

FDA grants rare pediatric disease designation for Leber congenital amaurosis gene therapy

FDA grants rare pediatric disease designation for Leber congenital amaurosis gene therapy

Opus Genetics received rare pediatric disease designation from the FDA for its ocular gene therapy designed to treat patients with a form of Leber congenital amaurosis, according to a press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails